Jim Cramer made the following calls on October 1st, 2013. What do you think about his picks?
ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on May 23, 2013. The stock’s 52-week high is $28.38, and its 52-week low is $1.80. Cramer gave a positive review of Acadia Pharmaceuticals, a biotech company that he believes could gain value independent of the budget debate in Washington. Acadia specializes in creating drugs to treat neurological and nervous system disorders, with their pimavanserin drug to treat Parkinson’s psychosis currently in phase III development.